ARCCARES CAPITAL CORP

Nasdaq arescapitalcorp.com


$ 21.33 $ 0.05 (0.23 %)    

Monday, 20-May-2024 15:59:55 EDT
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ 21.33
$ 21.31
$ 0.00 x 0
$ 0.00 x 0
$ 21.28 - $ 21.40
$ 16.69 - $ 21.42
4,523,316
na
12.61B
$ 1.14
nm
TBD
na
na ($ 0.09)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 10-23-2023 09-30-2023 10-Q
4 07-25-2023 06-30-2023 10-Q
5 04-25-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-K
7 10-25-2022 09-30-2022 10-Q
8 07-26-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-26-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 10-27-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-12-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-12-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-13-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-ares-capital-raises-price-target-to-22

JP Morgan analyst Melissa Wedel maintains Ares Capital (NASDAQ:ARCC) with a Overweight and raises the price target from $21....

 truist-securities-maintains-buy-on-ares-capital-raises-price-target-to-23

Truist Securities analyst Mark Hughes maintains Ares Capital (NASDAQ:ARCC) with a Buy and raises the price target from $22 t...

 oppenheimer-maintains-outperform-on-ares-capital-raises-price-target-to-22

Oppenheimer analyst Mitchel Penn maintains Ares Capital (NASDAQ:ARCC) with a Outperform and raises the price target from $21...

 ares-capital-q1-2024-adj-eps-059-misses-060-estimate-sales-701000m-beat-700133m-estimate

Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.60 ...

 jmp-securities-reiterates-market-outperform-on-ares-capital-maintains-21-price-target

JMP Securities analyst Devin Ryan reiterates Ares Capital (NASDAQ:ARCC) with a Market Outperform and maintains $21 price tar...

 cramer-says-this-healthcare-stock-can-go-higher-calls-manhattan-associates-a-winner

On CNBC’s "Mad Money Lightning Round," Jim Cramer said GE HealthCare Technologies Inc. (NASDAQ: GEHC) can go higher.

 ares-capital-q4-2023-adj-eps-063-beats-060-estimate-sales-70700m-beat-67823m-estimate

Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.60 by...

 earnings-scheduled-for-february-7-2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

 wells-fargo-maintains-equal-weight-on-ares-capital-raises-price-target-to-20

Wells Fargo analyst Timothy O'Shea maintains Ares Capital (NASDAQ:ARCC) with a Equal-Weight and raises the price target ...

 b-riley-securities-downgrades-ares-capital-to-neutral-announces-21-price-target

B. Riley Securities analyst Bryce Rowe downgrades Ares Capital (NASDAQ:ARCC) from Buy to Neutral and announces $21 price tar...

 jp-morgan-maintains-overweight-on-ares-capital-raises-price-target-to-21

JP Morgan analyst Melissa Gorham maintains Ares Capital (NASDAQ:ARCC) with a Overweight and raises the price target from $20...

 ares-capital-q3-core-eps-059
Ares Capital Q3 Core EPS $0.59
10/24/2023 10:22:08

Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.58 by...

 earnings-scheduled-for-october-24-2023

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is estimated to report earnings for its third quarter.

 citigroup-maintains-buy-on-ares-capital-raises-price-target-to-21

Citigroup analyst Arren Cyganovich maintains Ares Capital (NASDAQ:ARCC) with a Buy and raises the price target from $20 to $21.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION